Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-10-003467
Filing Date
2010-06-16
Accepted
2010-06-16 11:14:25
Documents
1
Period of Report
2010-06-11

Document Format Files

Seq Description Document Type Size
1 c61899_ex.html 4  
1 c61899_ex.xml 4 16767
  Complete submission text file 0000930413-10-003467.txt   18519
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Issuer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK CITY NY 10022
Business Address
Kent Stephen B H (Reporting) CIK: 0001387811 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09974 | Film No.: 10899791